|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 664.45 USD | +1.27% |
|
+0.24% | -13.92% |
| 15/07 | Alnylam Initiates Mid-Stage Study of Mivelsiran in Down Syndrome-Associated Alzheimer's | MT |
| 09/07 | Piper Sandler Adjusts Price Target on Regeneron Pharmaceuticals to $854 From $855 | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.27% | +0.24% | +8.04% | -11.87% | -13.92% | +21.26% | -7.53% | +12.75% | +77.75% | 6.76TCr | |
| +1.38% | -5.23% | -9.07% | -11.29% | -1.22% | +38.08% | +197.15% | +168.15% | +246.62% | 5.13TCr | |
| +1.10% | +38.30% | +38.30% | +38.30% | +38.30% | +38.30% | +38.30% | +38.30% | - | 4.3TCr | |
| +0.89% | -2.00% | +15.78% | -10.56% | -28.75% | -50.28% | -52.47% | -55.70% | +8.05% | 4.08TCr | |
| +2.76% | -1.56% | -0.70% | +9.25% | +12.07% | +54.70% | -29.29% | -39.90% | -24.23% | 2.91TCr | |
| +1.25% | -7.48% | +30.98% | +25.84% | +131.54% | +116.21% | -43.73% | -73.71% | - | 2.71TCr | |
| +0.18% | -1.85% | +12.86% | +18.53% | +16.52% | +68.63% | +86.35% | +43.88% | +37.29% | 2.3TCr | |
| -2.63% | +9.44% | +23.69% | +2.27% | +23.93% | +9.63% | +200.00% | +7.63% | - | 2.16TCr | |
| -1.70% | +5.53% | +21.56% | +6.38% | +8.07% | +76.00% | +353.68% | +39.30% | - | 1.62TCr | |
| +0.44% | -3.68% | +4.83% | +10.68% | +37.02% | +55.00% | +124.19% | +189.89% | +300.00% | 1.64TCr | |
| +0.96% | -3.27% | -6.26% | +28.97% | +30.05% | +115.70% | +222.60% | +318.41% | +2,850.68% | 1.22TCr | |
| +0.53% | -1.34% | +5.93% | +6.66% | -0.81% | +4.12% | -31.35% | -25.91% | -35.98% | 1.14TCr | |
| +3.22% | -7.97% | -17.34% | -22.65% | -35.82% | -38.49% | +603.66% | +291.19% | +4,319.57% | 1.04TCr | |
| +3.18% | -6.70% | +7.85% | +30.42% | +42.06% | +137.08% | +177.37% | +460.74% | - | 1.03TCr | |
| +2.81% | +7.35% | +38.76% | -12.66% | +30.91% | +31.72% | +354.70% | +320.84% | - | 711.89Cr | |
| -0.44% | +10.88% | +23.35% | +5.65% | +2.38% | +22.26% | +68.13% | -22.13% | - | 612.64Cr | |
| +2.06% | +0.22% | -0.75% | -4.47% | -15.70% | -22.48% | -27.49% | -56.23% | -54.33% | 621.81Cr | |
| +0.09% | +3.61% | +14.63% | +60.73% | +191.96% | +154.63% | +297.47% | -17.99% | - | 576.69Cr | |
| -1.05% | +5.65% | +8.98% | -27.93% | -25.72% | -35.74% | +146.70% | +111.05% | +124.50% | 579Cr | |
| +2.36% | +4.72% | +2.54% | -26.19% | -35.29% | -50.81% | -55.11% | -78.91% | - | 543.06Cr | |
| Average | +0.94% | +0.60% | +11.20% | +5.80% | +20.38% | +37.28% | +131.17% | +81.58% | +713.63% | 2.08TCr | |
| Weighted average by Cap. | +0.98% | -0.49% | +11.70% | +4.87% | +15.22% | +35.39% | +87.88% | +57.36% | +375.36% |
- Stock Market
- Stocks
- REGN Stock
- Sector Regeneron Pharmaceuticals, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition